Immune Response of Individuals Vaccinated With Hypoallergenic Derivatives of the Major Birch Pollen Allergen, Bet v 1

NCT01353924 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Allergy

Interventions

BIOLOGICAL: Bet v 1aF1-Alum + Bet v 1aF2-Alum
BIOLOGICAL: Alum-Placebo

Sponsor

Medical University of Vienna

Collaborators

[object Object]